Skip to main navigation Skip to search Skip to main content

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

  • Ivonne Haffner
  • , Katrin Schierle
  • , Elba Raimundez
  • , Birgitta Geier
  • , Dieter Maier
  • , Jan Hasenauer
  • , Birgit Luber
  • , Axel Walch
  • , Katharina Kolbe
  • , Jorge Riera Knorrenschild
  • , Albrecht Kretzschmar
  • , Beate Rau
  • , Ludwig Fischer Von Weikersthal
  • , Miriam Ahlborn
  • , Gabriele Siegler
  • , Stefan Fuxius
  • , Thomas Decker
  • , Christian Wittekind
  • , Florian Lordick
  • University Hospital Leipzig
  • Technical University of Munich
  • Rheinische Friedrich-Wilhelms-Universität Bonn
  • Biomax Informatics AG
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • Somnomar Institut für Medizinische Forschung und Schlafmedizin
  • MVZ Mitte
  • Charité – Universitätsmedizin Berlin
  • Klinikum St. Marien Amberg
  • Klinikum Braunschweig
  • Hematology and Medical Oncology
  • Onkologische Schwerpunktpraxis Heidelberg
  • Studienzentrum Onkologie Ravensburg

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Fingerprint

Dive into the research topics of 'HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Nursing and Health Professions

Immunology and Microbiology